Sign Up Today and Learn More About National Institutes of Health Stock
Invest in or calculate the value of your shares in National Institutes of Health or other pre-IPO companies through EquityZen's platform.

National Institutes of Health Stock (NIOH)
National Institutes of Health is a biomedical research facility in the United States that focuses on biomedical and health-related research.
About National Institutes of Health Stock
Founded
1887
Headquarters
Bethesda, MD, US
Industries
Science and Engineering, Health Care, Biotechnology
National Institutes of Health Press Mentions
Stay in the know about the latest news on National Institutes of Health
NIH launches new AI agent for analyzing genomic data
nextgov • Jul 29, 2025
AI agent improves accuracy of gene set analysis by leveraging expert-curated databases
phys • Jul 29, 2025
Trump administration asks US Supreme Court to allow NIH diversity-related cuts
marketscreener • Jul 25, 2025
Trump administration asks US Supreme Court to allow NIH diversity-related cuts
investing • Jul 24, 2025
ToolShell Attacks Hit 400+ SharePoint Servers, US Government Victims Named
securityweek • Jul 24, 2025
National Institutes of Health Management
Leadership team at National Institutes of Health
Chief
Jose Galvez
Head - Molecular Genetics & Carcinogenesis Section
Curtis Harris

Join now and verify your accreditation status to gain access to:
- National Institutes of Health Current Valuation
- National Institutes of Health Stock Price
- National Institutes of Health Management
- Available deals in National Institutes of Health and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- National Institutes of Health Cap Table and Funding History by Share Class and Liquidity Preferences
- National Institutes of Health Revenue and Financials
- National Institutes of Health Highlights
- National Institutes of Health Business Model
- National Institutes of Health Risk Factors
- National Institutes of Health Research Report from SACRA Research
Trading National Institutes of Health Stock
How to invest in National Institutes of Health stock?
Accredited investors can buy pre-IPO stock in companies like National Institutes of Health through EquityZen funds. These investments are made available by existing National Institutes of Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell National Institutes of Health stock?
Shareholders can sell their National Institutes of Health stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."